banner

Posts tagged as: new wound care products back to homepage

Excellagen Presentation on Cardium Therapeutics Website Excellagen Presentation on Cardium Therapeutics Website(0)

An updated presentation for Excellagen has been published on the Cardium Therapeutics (NYSE MKT: CXM) website.  The pdf file is available for viewing/dowloading at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations. Read More

OTCBB News

Electronic Control Security Lands Prime Government Contract Electronic Control Security Lands Prime Government Contract(0)
Balqon Lithium Battery System Installed in Hybrid Yacht Balqon Lithium Battery System Installed in Hybrid Yacht(0)
Ecosphere Delivers Two More Ozonix Water Treatment Units to Hydrozonix Ecosphere Delivers Two More Ozonix Water Treatment Units to Hydrozonix(0)
ALR Technologies Names Former Pfizer Exec as Chief Commercial Officer ALR Technologies Names Former Pfizer Exec as Chief Commercial Officer(0)
Cellceutix Enters $10 Million Share Purchase Agreement, Shares Jump Cellceutix Enters $10 Million Share Purchase Agreement, Shares Jump(0)
Drinks Americas Signs Sales Agreement for Marigold Craft Beer Drinks Americas Signs Sales Agreement for Marigold Craft Beer(0)
read more


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Gateways

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories
Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.